The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review
Background Revefenacin (REV) is a novel once-daily long-acting muscarinic antagonist (LAMA) in the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). This systematic review incorporating a dose-response meta-analysis aimed to assess the efficacy and safety of REV.Meth...
Saved in:
Main Authors: | Jiaxing Zhang (Author), Yihong Xie (Author), Joey Sum-wing Kwong (Author), Long Ge (Author), Rui He (Author), Wenyi Zheng (Author), Jing Han (Author), Rui Zhang (Author), Huaye Zhao (Author), Yuru He (Author), Xiaosi Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019
by: Jiaxing Zhang, et al.
Published: (2020) -
The Effectiveness of Clinical Pharmacist-Led Consultation in the Treatment of Infectious Diseases: A Prospective, Multicenter, Cohort Study
by: Jiaxing Zhang, et al.
Published: (2020) -
Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis
by: Jiaxing Zhang, et al.
Published: (2019) -
Efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and obstructive sleep apnea; a randomized controlled trial
by: Honghua Shen, et al.
Published: (2024) -
The Clinical Pharmacist-Led Consultation for Infectious Diseases in Guizhou Province, China: A Survey Among Hospital Pharmacies
by: Jiaxing Zhang, et al.
Published: (2020)